Wells Fargo & Company Beam Therapeutics Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 108,844 shares of BEAM stock, worth $3.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,844
Previous 61,753 76.26%
Holding current value
$3.08 Million
Previous $1.45 Million 84.37%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$22.57 - $33.14 $1.06 Million - $1.56 Million
47,091 Added 76.26%
108,844 $2.67 Million
Q2 2024

Aug 13, 2024
BUY
$21.22 - $32.66 $315,753 - $485,980
14,880 Added 31.75%
61,753 $1.45 Million
Q1 2024

May 10, 2024
BUY
$23.46 - $45.07 $232,887 - $447,409
9,927 Added 26.87%
46,873 $1.55 Million
Q4 2023

Feb 09, 2024
SELL
$17.69 - $30.76 $1.08 Million - $1.88 Million
-61,174 Reduced 62.35%
36,946 $1.01 Million
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $286,957 - $404,808
12,471 Added 14.56%
98,120 $2.36 Million
Q2 2023

Aug 15, 2023
BUY
$29.32 - $35.99 $764,548 - $938,475
26,076 Added 43.77%
85,649 $2.73 Million
Q1 2023

May 12, 2023
BUY
$30.15 - $48.79 $1.3 Million - $2.1 Million
43,014 Added 259.76%
59,573 $1.82 Million
Q4 2022

Feb 13, 2023
SELL
$36.73 - $51.6 $163,375 - $229,516
-4,448 Reduced 21.17%
16,559 $647,000
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $2.15 Million - $3.8 Million
-54,017 Reduced 72.0%
21,007 $1 Million
Q2 2022

Aug 12, 2022
SELL
$29.86 - $62.36 $433,119 - $904,531
-14,505 Reduced 16.2%
75,024 $2.9 Million
Q1 2022

May 16, 2022
BUY
$53.73 - $82.16 $1.26 Million - $1.92 Million
23,406 Added 35.4%
89,529 $5.13 Million
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $771,074 - $1.12 Million
11,336 Added 20.69%
66,123 $5.27 Million
Q3 2021

Nov 15, 2021
SELL
$84.37 - $133.6 $293,860 - $465,328
-3,483 Reduced 5.98%
54,787 $4.77 Million
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $810,220 - $1.63 Million
12,636 Added 27.69%
58,270 $7.5 Million
Q1 2021

May 13, 2021
BUY
$71.28 - $120.75 $529,752 - $897,414
7,432 Added 19.45%
45,634 $3.65 Million
Q4 2020

Feb 09, 2021
BUY
$22.24 - $95.63 $114,558 - $492,590
5,151 Added 15.59%
38,202 $3.12 Million
Q3 2020

Nov 05, 2020
BUY
$19.0 - $30.57 $351,652 - $565,789
18,508 Added 127.26%
33,051 $814,000
Q2 2020

Aug 13, 2020
BUY
$15.26 - $28.66 $101,326 - $190,302
6,640 Added 84.02%
14,543 $407,000
Q1 2020

May 14, 2020
BUY
$13.31 - $29.2 $105,188 - $230,767
7,903 New
7,903 $142,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.99B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email